Raw State JSON
{
"dispatched": [],
"mark_seen_result": {},
"messages": [],
"metadata": {
"artifact_uri": "s3://ace-llm-eval-artifacts-sb/results/online/blaw-health-legislation-relevancy/b7e832fc-c59d-4208-bd4f-546c7fbe0f63/c7682ef6-36fc-41cf-8593-044dfe56a9f3.json",
"llm_eval_run_id": "c7682ef6-36fc-41cf-8593-044dfe56a9f3"
},
"output": {
"classifier": {
"classifier_version": "v3",
"confidence": "high",
"purposes": [
"relevancy_determination"
],
"rationale": "step/enrichment routing table",
"skip": false,
"source": "step_route"
},
"run_id": "c7682ef6-36fc-41cf-8593-044dfe56a9f3",
"run_kind": "online",
"runtime_params": {
"action_id": "b7bf56de-9cc0-423b-be04-206083e11caa",
"enrichment_key": "blaw-health-legislation-relevancy",
"job_id": "b7e832fc-c59d-4208-bd4f-546c7fbe0f63",
"prompt_hash": "c3a15f39d4023362",
"s3_payload_uri": "s3://ace-llm-eval-artifacts-sb/emits/blaw-health-legislation-relevancy/b7e832fc-c59d-4208-bd4f-546c7fbe0f63/relevancy/a180d841-a53a-4e84-a0b8-759955066c2f.json",
"step_name": "relevancy",
"trace_id": "90782e76-1e0c-4f4c-b171-b7de12102434"
},
"verdicts": {
"relevancy_determination": {
"instruction_adherence": "pass",
"label_correctness": "pass",
"rationale": "The OUTPUT correctly identifies the bill as relevant to health care attorneys and compliance analysts. The bill amends sections of the New York Public Health Law and Insurance Law related to utilization review and pre-authorization standards, which directly impact health insurers, managed care organizations, and utilization review vendors. These changes also affect hospitals, health systems, clinics, physicians, pharmacies, and other providers that rely on timely pre-authorization and stability of approvals. The reasoning is grounded in the bill\u0027s text, which outlines specific compliance impacts such as evidence-based clinical review criteria, determination timeframes, required content of determinations, and validity of approvals. The analysis adheres to the instructions by focusing on provisions that impact the health care industry and summarizing these for health law attorneys.",
"reasoning_grounded": "pass",
"verdict": "accept"
}
}
},
"payloads": [],
"summary": {
"classifier": {
"classifier_version": "v3",
"confidence": "high",
"purposes": [
"relevancy_determination"
],
"rationale": "step/enrichment routing table",
"skip": false,
"source": "step_route"
},
"run_id": "c7682ef6-36fc-41cf-8593-044dfe56a9f3",
"run_kind": "online",
"runtime_params": {
"action_id": "b7bf56de-9cc0-423b-be04-206083e11caa",
"enrichment_key": "blaw-health-legislation-relevancy",
"job_id": "b7e832fc-c59d-4208-bd4f-546c7fbe0f63",
"prompt_hash": "c3a15f39d4023362",
"s3_payload_uri": "s3://ace-llm-eval-artifacts-sb/emits/blaw-health-legislation-relevancy/b7e832fc-c59d-4208-bd4f-546c7fbe0f63/relevancy/a180d841-a53a-4e84-a0b8-759955066c2f.json",
"step_name": "relevancy",
"trace_id": "90782e76-1e0c-4f4c-b171-b7de12102434"
},
"verdicts": {
"relevancy_determination": {
"instruction_adherence": "pass",
"label_correctness": "pass",
"rationale": "The OUTPUT correctly identifies the bill as relevant to health care attorneys and compliance analysts. The bill amends sections of the New York Public Health Law and Insurance Law related to utilization review and pre-authorization standards, which directly impact health insurers, managed care organizations, and utilization review vendors. These changes also affect hospitals, health systems, clinics, physicians, pharmacies, and other providers that rely on timely pre-authorization and stability of approvals. The reasoning is grounded in the bill\u0027s text, which outlines specific compliance impacts such as evidence-based clinical review criteria, determination timeframes, required content of determinations, and validity of approvals. The analysis adheres to the instructions by focusing on provisions that impact the health care industry and summarizing these for health law attorneys.",
"reasoning_grounded": "pass",
"verdict": "accept"
}
}
},
"watch_result": {}
}